Analysis of treatment strategy for a case of carbapenem-resistant Klebsiella pneumoniae pneumonia and urinary tract infection in an elderly patient with stroke

2019 ◽  
Vol 19 (4) ◽  
pp. 295-313
Author(s):  
Xiaoying WANG ◽  
Zhaohui LIN ◽  
Baiqian XING ◽  
Zhongdong LI
Author(s):  
Sanjith Saseedharan

Colistin is considered one of the last available therapeutic options to treat infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP).However, with an increase in the use of colistin to treat CRKP infections, colistin resistance is emerging and there are no standard treatment regimensfor these type of infections. In the present case report, we are discussing a case of 64-year-old male patient having complicated urinary tract infection(cUTI) by CRKP, treated successfully with ceftriaxone+sulbactam+EDTA (CSE-1034) and carbapenem combination therapy. Conclusively, CSE-1034 incombination with or without carbapenems could be a successful therapeutic option for the treatment of CRKP cUTI cases.


2021 ◽  
Vol 14 (2) ◽  
pp. e240351
Author(s):  
Antony Arumairaj ◽  
Sanket Agarwal ◽  
Tarun Popli ◽  
Eliana Lopez

The management of infections caused by carbapenem-resistant organisms has been a challenge. We report a rare emergence of resistance to the novel beta-lactam/ beta-lactamase combination ceftolozane/tazobactam by Klebsiella pneumoniae, causing urinary tract infection. The K. pneumoniae, in this case, was reported to be sensitive to the other novel beta-lactam/ beta-lactamase combination of ceftazidime/avibactam. The timely administration of ceftazidime/avibactam resulted in prompt clinical resolution of the urinary tract infection caused by an extensively drug-resistant K. pneumoniae.


Author(s):  
Alessandra Tammy Hayakawa Ito de Sousa ◽  
Marco Túlio dos Santos Costa ◽  
Herica Makino ◽  
Stéfhano Luis Cândido ◽  
Isabela de Godoy Menezes ◽  
...  

2013 ◽  
Vol 2 (1) ◽  
pp. 28-30 ◽  
Author(s):  
Nawshad Hayder ◽  
Zahidul Hasan ◽  
Sadia Afrin ◽  
Rashed Noor

Resistance of Klebsiella pneumoniae against carbapenem, imparted by the presence of carbapenemase, is an emerging global health problem with high morbidity and mortality. Thus, the present study attempted to detect the frequency of carbapenemase producing K. pneumoniae in Dhaka city of Bangladesh and thereby determine the health risk associated with their presence. A total of 647 K. pneumoniae isolates were detected from 2800 patients with urinary tract infection, bacterimia, wound infections and respiratory diseases. Thirty one carbapenem resistant isolates were found to harbor K. pneumoniae carbapenemase (KPC) through modified Hodge test. The KPC positive isolates were then subjected to the study of antibiogram and showed resistance against all the ß-lactam antibiotics along with carbapenems, while they were sensitive against colistin. Additionally, 287 isolates were found to be extended-spectrum ?-lactamases (ESBLs) positive apart from the KPC positive ones. DOI: http://dx.doi.org/10.3329/sjm.v2i1.15210 Stamford Journal of Microbiology, Vol.2(1) 2012: 28-30


2021 ◽  
pp. 54-55
Author(s):  
Jayesh Kalbhande ◽  
Vicky Kuldeep

Drug resistance of bacteria is biggest challenge humanity is going to face in near future. Bacteria are rapidly developing resistant to multiple drugs and there are not many new drugs in pipeline. Infection because of drug resistant organism is a common cause of morbidity and mortality in intensive care unit. If acquisition of drug resistance by microorganism progresses at this rate, that time is not very far when we will be pushed in to preantibiotic era. We need to develop new strategies to combat drug resistant by microorganism. We report a case of highly drug resistant urinary tract infection caused by Klebsiella. This strain was resistant to both Inj. Meropenem and Inj. Amikacin. This case was successfully treated by combination of Inj. Meropenem and Inj. Amikacin and complete resolution of infection was observed.


2020 ◽  
Vol 11 (2) ◽  
pp. 2424-2432
Author(s):  
Nabil Salim Saaid Tuwaij ◽  
Huda Jameel Baker Al-khilkhali ◽  
Haneen Mohamed Mohsen

Klebsiella pneumoniae is a significant concern multidrug-resistant microorganism and a one common gram negative bacteria associated with infections of women urinary tract. Therefore, this work aimed to the molecular screening of Sul(1and 2), Gyr(A and B) and OXA genes among K. pneumoniae isolates in Najaf City, Iraq. Out of 250 urine specimens were collected from women showing symptoms of urinary tract infection during five months January to of May 2019, bacterial growth was157 isolates, included 133 gram negative compared with  24 gram positive bacteria while 98 specimens were no growth. According to the Vitek-2 system, 30 K. pneumoniae isolates were obtained.Data on current work revealed that the 26-35 age group was the highest 14 K. pneumoniae isolates. Results of antimicrobial susceptible recorded all isolates were multi-drug resistant (MDR) and they have a different range of resistance. However, all 30 isolates(100%) resistant to ampicillin drugs, while the lowest rate was 1(3.33%) forImipenemdrug. PCR assay revealed exist of oxa, sul-1, sul-2, gyr-A and gyr-B genes among K. pneumoniae isolates with rates 20(66.66%), 11(36.66%), 22(73.33%), 3(10%) and 17(56.66%) respectively.


Cureus ◽  
2017 ◽  
Author(s):  
Faizan Yasin ◽  
Salman Assad ◽  
Abdul Subhan Talpur ◽  
Mehr Zahid ◽  
Shuja A Malik

Sign in / Sign up

Export Citation Format

Share Document